Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical Trials

Hip Osteoarthritis Clinical Trial

Official title:

Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical Trials

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05930067
• Other study ID #: HS23122 - HS25079
• Status: Active, not recruiting
• Phase: N/A
• Start date: May 2, 2023
• Est. completion date: August 2025

Study information

• Verified date: December 2023
• Source: Canadian Radiostereometric Analysis Network
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The proposed study is a continuation of two prospective, multi-centre, non-controlled studies of the Pinnacle and Pinnacle Dual Mobility total hip arthroplasty systems, originally initiated by DePuy Synthes (DSJ_2018_02 and DJS_2019_02, respectively).

Description:

The primary study objective is to establish the mean superior migration of the Pinnacle Gription Sector acetabular cup, irrespective of standard or dual mobility articulation, using model-based radiostereometric analysis. As both prior studies utilize the same acetabular component, a combined analysis will be performed with an additional sub-analysis on those with a Pinnacle Dual Mobility system. Additional objectives include comparison of acetabular cup migration between surgical approach groups (posterolateral, direct lateral, direct anterior) at all time points, linear head penetration at 1 and 2 years, as well as functional and health status outcomes. Patients will be followed to the original end point of 2 years post-surgery using the same radiographic and patient-reported outcome measures at the primary studies; Harris Hip Score, Hip Evaluation, HOOS Jr., and Forgotten Joint Score. Results of this study will be published in orthopaedic journals.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 82
• Est. completion date: August 2025
• Est. primary completion date: January 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Individuals who were enrolled on the DSJ_2018_02 and DSJ_2019_02.

Exclusion Criteria:

1. Individuals have active local or systemic infection.

2. Individuals who have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.

3. Individuals with poor bone quality, such as osteoporosis, where in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of bone fracture and/or the lack of adequate bone to support the implant(s).

4. Individuals with Charcot's or Paget's disease.

5. Individuals who, in the judgement of the investigator, would not be a candidate for protocol allowable components to be used for their THA.

6. Women who are pregnant or lactating.

7. Individuals who have had a contralateral hip that was implanted less than 6 months prior to the time of consent into this study or individuals that expect to have a contralateral hip implanted in the 6 months following the time of consent into this study. Individuals that have amputations in either leg that would impact rehabilitation following surgery.

8. Individuals who are bedridden per the Investigators determination.

9. Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months.

10. Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims.

11. Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have a psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.

12. Individuals diagnosed and taking prescription medications to treat a muscular disorder that limits mobility due to sever stiffness and pain such as fibromyalgia or polymyalgia.

13. Subject has a medical condition with less than 2 years life expectancy.

14. Individual has a BMI >45 kg/m2.

15. DSJ-2019-02 only: Individuals who require revision arthroplasty and have a well-fixed non-DePuy Synthes femoral stem or a well-fixed DePuy Synthes femoral stem that does not have a polished neck

Related Conditions & MeSH terms

• Hip Osteoarthritis
• Osteoarthritis, Hip

Intervention

Device:
• Pinnacle Gription Acetabular Cup
Pinnacle Gription cup with Corail/ACTIS stem
• Pinnacle Dual Mobility
Bi-Mentum AltrX liner

Locations

Country	Name	City	State
Canada	London Health Sciences Centre	London	Ontario
Canada	Orthopaedic Innovation Centre	Winnipeg	Manitoba

Sponsors (2)

Lead Sponsor	Collaborator
Canadian Radiostereometric Analysis Network	DePuy Synthes

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in RSA Migrations from baseline(6-week) to 6-month, 1-year and 2-year	Stability over a period of two year measured by migration (mm) with Röntgen Stereometric Analysis	Post-op: 6-weeks, 3-months, 6-months, 1-year, 2-year
Secondary	Subsidence profiles	Comparing RSA exams at the specified time points to determine relative movement of the device	6-months, 1-year, 2-year
Secondary	Change of functional outcome over 2 year follow-up period (Harris Hip Score)	The Harris Hip Score (HHS) is a score used in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100, any result <70 is considered a poor result; The HHS is an outcome measure administered by a qualified health care professional.	Preoperative, 6 weeks, 3 months, 6 months, 12 months and 2 years postoperatively
Secondary	Pain and Function	The Hip Disability and Osteoarthritis Outcome score - joint replacement (HOOS JR) will be used. The HOOS-JR is a joint replacement survey designed to measure pain and function.	Preoperative, 6 weeks, 3 months, 6 months, 12 months and 2 years postoperatively
Secondary	Forgotten Joint Score (FJS)	The FJS total score range is 0-100, higher scores indicating the patient is able to forget the joint daily lower degree of joint awareness.	Preoperative, 6 weeks, 3 months, 6 months, 12 months and 2 years postoperatively
Secondary	Complications	Evaluate the type and frequency of the complications/adverse events.	Preoperative, 6 weeks, 3 months, 6 months, 12 months and 2 years postoperatively